Trial intelligence / Profile preview

Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetes

NCT03792321Phase 4Completed

Sponsor
University Medical Centre Ljubljana
Start
Jan 2014
Primary completion
Mar 2015
Modality
Hormone, Biologic
01

Overview

Phase 4, randomised, double-blind trial in Hypogonadism comparing Testosterone Arm with Placebo Arm (2 arms). Primary endpoints: Fasting Plasma Glucose at 24 months, Glycated Hemoglobin A1c at 24 months and 3 more. Started Jan 2014; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT03792321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03792321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call